Karuna Therapeutics, Inc.

NASDAQ:KRTX

329.83 (USD) • At close March 15, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -113.824-119.119-103.163-97.574-76.212-76.963-64.943-58.218-27.96-50.932-34.416-30.497-24.009-18.841-17.046-8.658-7.774-9.038-15.14-12.005-8.327-6.238-0.539-2.408
Depreciation & Amortization 0.4470.4580.4690.3270.3050.290.2690.2480.2360.1060.0520.1120.0480.0430.0330.0210.0210.0150.0120.010.00400.0010.001
Deferred Income Tax 112.5140-112.51400000000000000000.135-0.0110-2.2660.08
Stock Based Compensation 22.79318.29618.00315.50712.66212.02112.13210.6368.328.2037.4665.8224.4674.1443.2261.6340.9811.6426.8413.1040.4410.4070.0560.054
Change In Working Capital -10.0761.27929.908-11.584-10.8325.49612.864-2.75412.053-1.497-2.1972.486-4.416-7.928-2.36-0.8760.425-0.53-1.5432.2470.838-0.073-3.3250.704
Accounts Receivables 0000.0570.0244.669-4.751.75-1.75000000000000000
Change In Inventory 000000000000000000000000
Change In Accounts Payables 3.9341.7230.593-1.903-13.53411.812.448-0.4810.066-0.0960.7790.322-0.260.4120.1420.0240.389-0.364-0.3320.5850.0730.176-1.6460.868
Other Working Capital -14.01-0.44429.3151.8462.678-10.98315.166-4.02313.737-1.401-2.9762.164-4.156-8.34-2.502-0.90.036-0.166-1.2111.6620.765-0.249-1.679-0.164
Other Non Cash Items -122.913-10.911103.163-7.305-4.68-0.790.1780.2850.3530.3120.2020.8980.965-0.1990.358-0.462-0.473-0.5050.2570.3950.1913.7730.3920.868
Operating Cash Flow -111.059-109.997-64.134-100.629-78.757-59.946-39.5-49.803-6.998-43.808-28.893-21.179-22.945-22.781-15.789-8.341-6.82-8.416-9.573-6.114-6.864-2.131-5.681-0.701
Investing Activities:
Investments In Property Plant And Equipment -0.799-0.629-0.775-0.714-0.29-0.174-0.4510.206-0.769-1.517-0.739-0.047-0.082-0.104-0.157-0.076-0.04-0.005-0.053-0.017-0.132000
Acquisitions Net -0.847-28.939252.8050.8471.221291.846003.149000.0660.419000.197-64.3530000000
Purchases Of Investments -226.187-367.861-605.803-320.677-470.927-368.846-42.204-48.303-111.325-99.054-109.594-80.856-80.239-131.726-61.898-70.35-100.077-67.17300-4.983000
Sales Maturities Of Investments 319.426396.8352.998293.9164.6017737.166.09970.07450.202128.937132109.98265206027.49825050000
Other Investing Activites 0.84728.939-252.805-0.847-1.221-291.846-5.104-0.206-3.14900-0.066-0.41900-0.19764.3530-64.46800000
Investing Cash Flow 92.4428.31-253.58-27.491-306.616-292.02-5.55517.796-42.02-50.36918.60451.09729.661-66.83-42.055-10.426-72.619-42.178-64.5214.983-5.115000
Financing Activities:
Debt Repayment 000000000000000000000000
Common Stock Issued 24.3912.65918.396442.451000000004.098000234.6240000000
Common Stock Repurchased 000000000000000000000000
Dividends Paid 000000000000000000000000
Other Financing Activities -4.5240005.385844.1874.9481.2573.750.7492.253270.823-2.5530.5251.0720.517-0.494.2430.31476.5022.717.87743
Financing Cash Flow 19.8672.65918.396442.4515.385844.1874.9481.2573.750.7492.253270.8231.5450.5251.0720.517234.22494.2430.31476.5022.717.87743
Other Information:
Effect Of Forex Changes On Cash -196.1550196.155000000000000000000000
Net Change In Cash 1.248-79.028-299.318314.331-379.988492.221-40.107-30.75-45.268-93.428-8.036300.7418.261-89.086-56.772-18.25154.78543.649-73.7875.371-9.27915.746-1.6812.299
Cash At End Of Period 185.823184.575263.603562.921248.59628.578136.357176.464207.214252.482345.91353.94653.20544.944134.03190.802209.05254.26710.61884.3989.02718.3062.564.241